Tesla Motors Inc (TSLA) shed almost 6% of its value to become one of the worst performing stocks on Friday, after news broke that the electric car company will now receive fewer benefits from the State of California’s environmental credit initiative. The news came amid a broad selloff in momentum stocks in last week’s final trading session, and was followed by a sharp decline in Tesla’s stock price. Tesla Motors Inc (NASDAQ:TSLA) shares after opening at $200.61 moved to $207.00 on last trade day and at the end of the day closed at $203.78. Company price to sales ratio in past twelve months was calculated as 12.47 and price to cash ratio as 29.68. Tesla Motors Inc (NASDAQ:TSLA) showed a negative weekly performance of -3.98%.
Intel Corporation (NASDAQ:INTC) will report its first quarter earnings after the market close on April 15. Goldman Sachs analysts James Covello, Gabriela Borges and Chelsea Jurman, in a report dated April 10, 2014, expect the chip maker to post sales above the guidance range of $12.8 billion (mid point), which is a 7% decline quarter over quarter. Intel Corporation (NASDAQ:INTC) shares fell -0.93% in last trading session and ended the day on $26.18. INTC return on equity ratio is recorded as 17.60% and its return on assets is 10.90%. Intel Corporation (NASDAQ:INTC) yearly performance is 25.44%.
Pfizer Inc. (NYSE:PFE) announced yesterday that its phase 2 randomized study, PALOMA-1, of palbociclib combined with letrozole, achieved its primary endpoint. The endpoint was to achieve an increase in progression-free survival (PFS), which limits the disease from getting worse after taking the drug. The combination therapy was able achieve 20.2 months of PFS, which means that those given the drug lived without the disease getting worse for 20.2 months, which is twice the length of those who were given letrozole alone. Pfizer Inc. (NYSE:PFE) shares moved down -2.45% in last trading session and was closed at $3.55, while trading in range of $29.83 – 30.50. Pfizer Inc. (NYSE:PFE) year to date (YTD) performance is -1.71%.
National Bank of Greece S.A. (NYSE: NBG) is trying to still manage a turnaround. If earnings are a barometer, then the bank could be on the way back up. The question is whether this sort of earnings is a one-off or indicative of more gains to come. Using year-over-year comparisons is not easy because of mergers and because of banking system changes. National Bank of Greece (ADR)(NYSE:NBG) weekly performance is -5.25%. On last trading day company shares ended up $5.23. National Bank of Greece (ADR)(NYSE:NBG) distance from 50-day simple moving average (SMA50) is 2.40%. Analysts mean target price for the company is $5.71.